ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Bugspray
|
175 |
27K |
8 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
175
|
27K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Bugspray
|
175 |
27K |
5 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
175
|
27K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Bugspray
|
971 |
225K |
20 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
971
|
225K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Bugspray
|
304 |
71K |
9 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
304
|
71K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Bugspray
|
971 |
225K |
17 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
971
|
225K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
Bugspray
|
209 |
45K |
2 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
45K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
Bugspray
|
209 |
45K |
9 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
209
|
45K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
Bugspray
|
209 |
45K |
32 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
209
|
45K
|
32
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Bugspray
|
114 |
30K |
12 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
30K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Bugspray
|
114 |
30K |
14 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
30K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Bugspray
|
971 |
225K |
5 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
971
|
225K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Bugspray
|
197 |
48K |
29 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
197
|
48K
|
29
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Bugspray
|
164 |
37K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
164
|
37K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Bugspray
|
430 |
102K |
21 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
430
|
102K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Bugspray
|
430 |
102K |
7 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
430
|
102K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Grants PharmAust Pre-IND Meeting
|
|
Bugspray
|
61 |
16K |
9 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
61
|
16K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Grants PharmAust Pre-IND Meeting
|
|
Bugspray
|
61 |
16K |
5 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
61
|
16K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Grants PharmAust Pre-IND Meeting
|
|
Bugspray
|
61 |
16K |
3 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
61
|
16K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust brand name required
|
|
Bugspray
|
30 |
5.9K |
10 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
30
|
5.9K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Bugspray
|
205 |
40K |
3 |
17/06/23 |
17/06/23 |
ASX - By Stock
|
205
|
40K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Bugspray
|
164 |
37K |
9 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
164
|
37K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Bella's Monepantel Trial
|
|
Bugspray
|
127 |
27K |
6 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
127
|
27K
|
6
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Bugspray
|
136K |
51M |
4 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
136K
|
51M
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Bugspray
|
61 |
13K |
4 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
61
|
13K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient of Cohort 2 Dosed in MND Trial
|
|
Bugspray
|
79 |
17K |
4 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
79
|
17K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Bella's Monepantel Trial
|
|
Bugspray
|
127 |
27K |
8 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
127
|
27K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Bella's Monepantel Trial
|
|
Bugspray
|
127 |
27K |
14 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
127
|
27K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust canine trial update
|
|
Bugspray
|
51 |
11K |
3 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
51
|
11K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust canine trial update
|
|
Bugspray
|
51 |
11K |
8 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
51
|
11K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Interactive AGM Yes/No vote
|
|
Bugspray
|
87 |
12K |
5 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
87
|
12K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Bella's Monepantel Trial
|
|
Bugspray
|
127 |
27K |
20 |
22/01/23 |
22/01/23 |
ASX - By Stock
|
127
|
27K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Bugspray
|
164 |
37K |
12 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
164
|
37K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Bugspray
|
164 |
37K |
9 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
164
|
37K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient Dosed in MND Phase 1/2 Trial
|
|
Bugspray
|
171 |
42K |
17 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
171
|
42K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Bugspray
|
207 |
46K |
2 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
207
|
46K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Bugspray
|
207 |
46K |
2 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
207
|
46K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Bugspray
|
207 |
46K |
5 |
13/11/22 |
13/11/22 |
ASX - By Stock
|
207
|
46K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: AGM Presentation
|
|
Bugspray
|
54 |
9.4K |
7 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
54
|
9.4K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
AGM week - Caption this
|
|
Bugspray
|
26 |
5.0K |
10 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
26
|
5.0K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 Shareholders as at 31 October 2022 with variations
|
|
Bugspray
|
9 |
2.4K |
11 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
9
|
2.4K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Bugspray
|
1.4K |
365K |
4 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
1.4K
|
365K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Bugspray
|
1.4K |
365K |
3 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
1.4K
|
365K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 shareholders with variations as at 30 June 2022:
|
|
Bugspray
|
6 |
1.7K |
2 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
6
|
1.7K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 shareholders with variations as at 30 June 2022:
|
|
Bugspray
|
6 |
1.7K |
2 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
6
|
1.7K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 shareholders with variations as at 30 June 2022:
|
|
Bugspray
|
6 |
1.7K |
2 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
6
|
1.7K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Science Week Conference Presentation
|
|
Bugspray
|
24 |
5.8K |
14 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
24
|
5.8K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Bugspray
|
1.4K |
365K |
10 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
1.4K
|
365K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Charting PAA
|
|
Bugspray
|
899 |
200K |
15 |
19/06/22 |
19/06/22 |
ASX - By Stock
|
899
|
200K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust ready to trial monepantel on humans to fight motor neurone disease
|
|
Bugspray
|
29 |
7.3K |
5 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
29
|
7.3K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Company Zoom Meeting
|
|
Bugspray
|
23 |
5.3K |
9 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
23
|
5.3K
|
9
|
|